AAAAAA

   
Results: 1-10 |
Results: 10
TAFII70 protein in Cajal bodies of the amphibian germinal vesicle
Authors: Bucci, S Giani, L Mancino, G Pellegrino, M Ragghianti, M
Citation: S. Bucci et al., TAFII70 protein in Cajal bodies of the amphibian germinal vesicle, GENOME, 44(6), 2001, pp. 1100-1103
Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia
Authors: Lissoni, P Bucovec, R Bonfanti, A Giani, L Mandelli, A Roselli, MG Rovelli, F Fumagalli, L
Citation: P. Lissoni et al., Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia, J PINEAL R, 30(2), 2001, pp. 123-126
Blanket development in a malting wastewater anerobic treatment
Authors: Martinez, J Lopez, I Giani, L Borzacconi, L
Citation: J. Martinez et al., Blanket development in a malting wastewater anerobic treatment, WATER SCI T, 44(4), 2001, pp. 57-62
Initial marsh soil development from brackish sediments
Authors: Giani, L Landt, A
Citation: L. Giani et A. Landt, Initial marsh soil development from brackish sediments, J PLANT NU, 163(5), 2000, pp. 549-553
Expression of TAFII70 RNA and protein during oogenesis and development of the amphibian Pleurodeles waltl
Authors: Giani, L Bucci, S Ragghianti, M Mancino, G
Citation: L. Giani et al., Expression of TAFII70 RNA and protein during oogenesis and development of the amphibian Pleurodeles waltl, MECH DEVEL, 99(1-2), 2000, pp. 191-194
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients
Authors: Bordin, V Giani, L Meregalli, S Bukovec, R Vaghi, MM Mandala, M Paolorossi, F Ardizzoia, A Tancini, G Barni, S Frigerio, F Fumagalli, L Bordoni, A Valusani, G Di Felice, G Lissoni, P
Citation: V. Bordin et al., Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients, UROL INTERN, 64(1), 2000, pp. 3-8
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study
Authors: Lissoni, P Tancini, G Paolorossi, F Mandala, M Ardizzoia, A Malugani, F Giani, L Barni, S
Citation: P. Lissoni et al., Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study, J PINEAL R, 26(3), 1999, pp. 169-173
Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease
Authors: Lissoni, P Vigore, L Ferranti, R Bukovec, R Meregalli, S Mandala, M Barni, S Tancini, G Fumagalli, L Giani, L
Citation: P. Lissoni et al., Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease, J BIOL REG, 13(4), 1999, pp. 216-219
Endocrinological study of the dopaminergic regulation of prolactin releasein metastatic breast cancer
Authors: Mandala, M Lissoni, P Ardizzoia, A Barni, S Rovelli, F Confalonieri, G Malugani, F Moro, C Fumagalli, G Giani, L Tancini, G
Citation: M. Mandala et al., Endocrinological study of the dopaminergic regulation of prolactin releasein metastatic breast cancer, TUMORI, 85(6), 1999, pp. 494-497
Negative influence of morphine on the efficacy of interleukin-2 cancer immunotherapy
Authors: Lissoni, P Mandala, M Giani, L Brivio, F Paolorossi, F Bordoni, A Fumagalli, L
Citation: P. Lissoni et al., Negative influence of morphine on the efficacy of interleukin-2 cancer immunotherapy, INT J IMM T, 15(1), 1999, pp. 31-34
Risultati: 1-10 |